BNAI Q3 2025 Earnings EPS Beat Surprises Market but Revenue Remains Absent BHFAM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions Grace Therapeutics Q1 2026 Earnings EPS Surprise of 5098 Despite No Revenue as Stock Declines C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution Similarweb Q1 2026 Earnings EPS Slightly Below Estimates but Shares Rally on Strategic Momentum Lexicon Pharmaceuticals LXRX Slides 314 as Shares Test NearTerm Support Levels FBS Global Limited FBGL Surges 1034 Navigating Key Resistance at 068 Enovis Corporation ENOV Sinks 715 Assessing Support Levels and Potential Reversal American Financial Group Debentures AFGE Edge Lower as Bond Market Headwinds Persist UHAL Q1 2026 Earnings EPS Misses Estimates Significantly Stock Rises Despite Loss